Invesco Dynamic Biotechnology & Genome ETF (PBE)
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
$326.74M
Jun 23, 2005
19.03
$3.77
Sector weights (10)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (28)
United Therapeutics Corporation
UTHR
5.205%
Biogen Inc.
BIIB
5.195%
Amgen Inc.
AMGN
5.157%
Illumina, Inc.
ILMN
4.998%
Regeneron Pharmaceuticals, Inc.
REGN
4.952%
BioMarin Pharmaceutical Inc.
BMRN
4.888%
Alnylam Pharmaceuticals, Inc.
ALNY
4.631%
Neurocrine Biosciences, Inc.
NBIX
4.143%
MannKind Corporation
MNKD
3.162%
Novavax, Inc.
NVAX
2.992%
ACADIA Pharmaceuticals Inc.
ACAD
2.927%
Repligen Corporation
RGEN
2.889%
Bio-Techne Corporation
TECH
2.887%
Collegium Pharmaceutical, Inc.
COLL
2.823%
Protagonist Therapeutics, Inc.
PTGX
2.817%
Myriad Genetics, Inc.
MYGN
2.813%
Exelixis, Inc.
EXEL
2.804%
BioCryst Pharmaceuticals, Inc.
BCRX
2.781%
Catalyst Pharmaceuticals, Inc.
CPRX
2.747%
TG Therapeutics, Inc.
TGTX
2.735%
OPKO Health, Inc.
OPK
2.712%
Natera, Inc.
NTRA
2.693%
Halozyme Therapeutics, Inc.
HALO
2.688%
Incyte Corporation
INCY
2.678%
Blueprint Medicines Corporation
BPMC
2.662%
Veracyte, Inc.
VCYT
2.561%
CareDx, Inc
CDNA
2.445%
Vericel Corporation
VCEL
2.422%
Sector weights (10)
Health Care Select Sector SPDR Fund
XLV
100%
Utilities Select Sector SPDR Fund
XLU
0%
Technology Select Sector SPDR Fund
XLK
0%
The Real Estate Select Sector SPDR Fund
XLRE
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
Materials Select Sector SPDR Fund
XLB
0%
ETF Constituents (28)
United Therapeutics Corporation
UTHR
5.205%
Biogen Inc.
BIIB
5.195%
Amgen Inc.
AMGN
5.157%
Illumina, Inc.
ILMN
4.998%
Regeneron Pharmaceuticals, Inc.
REGN
4.952%
BioMarin Pharmaceutical Inc.
BMRN
4.888%
Alnylam Pharmaceuticals, Inc.
ALNY
4.631%
Neurocrine Biosciences, Inc.
NBIX
4.143%
MannKind Corporation
MNKD
3.162%
Novavax, Inc.
NVAX
2.992%
ACADIA Pharmaceuticals Inc.
ACAD
2.927%
Repligen Corporation
RGEN
2.889%
Bio-Techne Corporation
TECH
2.887%
Collegium Pharmaceutical, Inc.
COLL
2.823%
Protagonist Therapeutics, Inc.
PTGX
2.817%
Myriad Genetics, Inc.
MYGN
2.813%
Exelixis, Inc.
EXEL
2.804%
BioCryst Pharmaceuticals, Inc.
BCRX
2.781%
Catalyst Pharmaceuticals, Inc.
CPRX
2.747%
TG Therapeutics, Inc.
TGTX
2.735%
OPKO Health, Inc.
OPK
2.712%
Natera, Inc.
NTRA
2.693%
Halozyme Therapeutics, Inc.
HALO
2.688%
Incyte Corporation
INCY
2.678%
Blueprint Medicines Corporation
BPMC
2.662%
Veracyte, Inc.
VCYT
2.561%
CareDx, Inc
CDNA
2.445%
Vericel Corporation
VCEL
2.422%